ArticleCancer medicine2026

Efficacy and Safety of Low-Frequency Daratumumab Regimen in Systemic Light-Chain Amyloidosis.

Jintao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.